(Q40753492)

English

Discovery of MK-1421, a Potent, Selective sstr3 Antagonist, as a Development Candidate for Type 2 Diabetes

scientific article published on 18 March 2015

Statements

Discovery of MK-1421, a Potent, Selective sstr3 Antagonist, as a Development Candidate for Type 2 Diabetes (English)
1 reference
Shrenik K Shah
1 reference
Shuwen He
1 reference
Liangqin Guo
1 reference
Quang Truong
1 reference
Hongbo Qi
1 reference
Wu Du
1 reference
Zhong Lai
1 reference
Jian Liu
1 reference
Tianying Jian
1 reference
Qingmei Hong
1 reference
Peter Dobbelaar
1 reference
Zhixiong Ye
1 reference
Edward Sherer
1 reference
Zhe Feng
1 reference
Yang Yu
1 reference
Frederick Wong
1 reference
Koppara Samuel
1 reference
Maria Madiera
1 reference
Bindhu V Karanam
1 reference
Vijay B Reddy
1 reference
Stan Mitelman
1 reference
Sharon X Tong
1 reference
Gary G Chicchi
1 reference
Kwei-Lan Tsao
1 reference
Dorina Trusca
1 reference
Yue Feng
1 reference
Margaret Wu
1 reference
Qing Shao
1 reference
Maria E Trujillo
1 reference
George J Eiermann
1 reference
Cai Li
1 reference
Michele Pachanski
1 reference
Guillermo Fernandez
1 reference
Donald Nelson
1 reference
Patricia Bunting
1 reference
Pierre Morissette
1 reference
Sylvia Volksdorf
1 reference
Janet Kerr
1 reference
Bei B Zhang
1 reference
Andrew D Howard
1 reference
Yun-Ping Zhou
1 reference
Alexander Pasternak
1 reference
William K Hagmann
1 reference
18 March 2015
1 reference
6
1 reference
5
1 reference
513-517
1 reference

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit